Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 46Carcinoma, Transitional Cell 3Urologic Diseases 2Urinary Bladder Diseases 2Muscle Invasive Bladder Cancer 2Infiltrating Bladder Urothelial Carcinoma 2Carcinoma, Renal Cell 2Wound Infection 1Urologic Neoplasms 1Urinary Tract Infections 1Ureteral Neoplasms 1Transitional Cell Carcinoma of the Bladder 1Transitional Cell Bladder Cancer 1Stage 0is Bladder Urothelial Carcinoma 1Recurrence 1Prostatic Neoplasms 1Patient Satisfaction 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Non-metastatic Muscle Invasive Bladder Cancer 1Neoplasms 1Invasive Bladder Cancer 1Infections 1Ileus 1Disease Progression 1Cross Infection 1Cone Dystrophy 3 1Bladder Adenocarcinoma 1Bacterial Infections 1Adrenal Gland Neoplasms 1

Interventions

Lenalidomide 4Gemcitabine 4Dexamethasone 4Cyclophosphamide 4Bortezomib 4Nivolumab 3Cisplatin 3Carboplatin 3vandetanib 2tumor necrosis factor-alpha, CNGRC fusion protein, human 2pomalidomide 2pembrolizumab 2liposomal doxorubicin 2fludarabine 2durvalumab 2capivasertib 2Radiosurgery 2Paclitaxel 2Doxorubicin 2Bevacizumab 2Anthropogenic Effects 2venetoclax 1umbralisib 1ublituximab 1tremelimumab 1tivozanib 1ricolinostat 1regorafenib 1pazopanib 1niraparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease Progression × Cystectomy × Clear all
NCT06170177 2023-12-14

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

IRCCS San Raffaele

Recruiting
4,000 enrolled
Genitourinary

Urinary Bladder Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡